MedTrace Logo

Financial Incentives to Improve Asthma

NCT05322044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-02-05

Study results available
· View outcomes & findings →

Summary

The aim of this pilot randomised controlled trial is to assess the effectiveness of a short-term financial incentives intervention at bringing about behaviour change, namely short-medium term improvements in inhaled corticosteroid (ICS) adherence and asthma control in children and young people (CYP) with asthma.

Conditions

  • Asthma in Children
  • Medication Adherence

Interventions

BEHAVIORAL

Financial incentives

Financial incentives dependent upon adherence will be given to participants alongside additional EMD associated app features for 12-weeks.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Ian Maconochie · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-18
Primary Completion
2023-07-11
Completion
2023-09-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05322044 on ClinicalTrials.gov